Patents by Inventor Rita HABAR

Rita HABAR has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Novel therapeutical tools and methods for treating blindness
    Publication number: 20160250282
    Abstract: The present inventions relates to the use of an isolated nucleic acid molecule comprising a nucleotide sequence coding for a hyperpolarizing light-gated ion channel or pump gene from an archeon or for a light-active fragment of said gene, or the nucleotide sequence complementary to said nucleotide sequence, for treating or ameliorating blindness. The light-gated ion channel or pump gene can be a halorhodopsin gene.
    Type: Application
    Filed: January 25, 2016
    Publication date: September 1, 2016
    Applicant: Novartis Forschungsstiftung Zweigniederlassung Friedrich Miescher Institute for Biomedical Resear
    Inventor: Rita HABAR
  • Novel Therapeutical Tools and Methods for Treating Blindness
    Publication number: 20130059374
    Abstract: The present inventions relates to the use of an isolated nucleic acid molecule comprising a nucleotide sequence coding for a hyperpolarizing light-gated ion channel or pump gene from an archeon or for a light-active fragment of said gene, or the nucleotide sequence complementary to said nucleotide sequence, for treating or ameliorating blindness. The light-gated ion channel or pump gene can be a halorhodopsin gene.
    Type: Application
    Filed: September 13, 2012
    Publication date: March 7, 2013
    Inventors: Volker BUSSKAMP, Pamela LAGALI, Botond ROSKA, Rita HABAR
  • Novel Therapeutical Tools and Methods for Treating Blindness
    Publication number: 20120258530
    Abstract: The present inventions relates to the use of an isolated nucleic acid molecule comprising a nucleotide sequence coding for a hyperpolarizing light-gated ion channel or pump gene from an archeon or for a light-active fragment of said gene, or the nucleotide sequence complementary to said nucleotide sequence, for treating or ameliorating blindness. The light-gated ion channel or pump gene can be a halorhodopsin gene.
    Type: Application
    Filed: November 18, 2011
    Publication date: October 11, 2012
    Inventors: David BALYA, Rita HABAR, Volker BUSSKAMP, Pamela LAGALI, Botond ROSKA